Femto Technologies Secures $17 Million Investment to Advance Feminine Wellness Technology

Femto Technologies Inc., a FemTech pioneer, has secured $17 million through a private placement investment, positioning the company to advance its innovative feminine wellness technologies. The company will issue common shares and warrants to institutional investors at $4.17 per common unit, with the transaction expected to close on February 27, 2025. The investment round includes the sale of common units comprising common shares, Series A warrants, and Series B PIPE common warrants. Series A warrants will have an initial exercise price of $5.21 per common share and expire 60 months after issuance, while Series B warrants will have an initial exercise price of $12.51 per common share and expire 30 months after issuance.

Femto plans to utilize the net proceeds from the offering for general corporate purposes and working capital. The funding will support further development of Sensera, the company's feminine wellness device that integrates proprietary Smart Release System (SRS) technology featuring machine learning and artificial intelligence. The Sensera device, which recently received a CES Innovation Awards® 2025 Honorary designation in the AI category, represents Femto's commitment to bridging gaps in feminine wellness through advanced technological solutions. The device is designed to provide a holistic self-care experience that adapts to women's changing needs.

Aegis Capital Corp. is serving as the exclusive placement agent for this private placement. The securities are being offered solely to accredited investors in a private transaction not involving a public offering, and have not been registered under the Securities Act of 1933. This financial milestone underscores Femto Technologies' strategic positioning in the emerging FemTech market, signaling continued innovation and potential growth in female wellness technologies. The substantial funding injection demonstrates investor confidence in the company's technological approach to addressing women's health needs through artificial intelligence and machine learning applications.

The $17 million investment represents a significant validation of Femto's business model and technological direction within the rapidly expanding FemTech sector. By securing this level of funding through institutional investors, the company strengthens its financial foundation to pursue research and development initiatives while scaling its operations. The combination of common shares and warrants in the financing structure provides both immediate capital and potential future funding opportunities through warrant exercises, creating a flexible financial framework for the company's growth trajectory in the competitive feminine wellness technology landscape.